Walter M.A. Westerink

Author

SNV Netherlands Development Organisation

Also Known As

W. Westerink, W.M.A. Westerink, Walter M. A. Westerink, Walter M.A. Westerink, Walter Westerink

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

SNV Netherlands Development Organisation Inserm

About

Walter M.A. Westerink is an author at SNV Netherlands Development Organisation specializing in medicine, pharmacology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.3K
2	Biochemistry	6	6	950
3	Natural Sciences	2	2	732
4	Engineering	1	1	14
5	Health Sciences	1	1	26

Walter M.A. Westerink

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells Walter M.A. Westerink, W.G.E.J. Schoonen Toxicology in Vitro Oxidative StressHepatotoxicityMetabolismPrimary Human HepatocytesBiochemistry	2007	519
Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells Walter M.A. Westerink, W.G.E.J. Schoonen Toxicology in Vitro HepatologyBiochemistryMedicineLiver PhysiologyHepg2 Cells	2007	213
Cytotoxic effects of 110 reference compounds on HepG2 cells and for 60 compounds on HeLa, ECC-1 and CHO cells. W.G.E.J. Schoonen, Jeroen A.D.M. de Roos, Walter M.A. Westerink, Toxicology in Vitro Cytotoxic EffectsMedicineCellular PharmacologyCho CellsHepatotoxicity	2005	130
Cytotoxic effects of 100 reference compounds on Hep G2 and HeLa cells and of 60 compounds on ECC-1 and CHO cells. I Mechanistic assays on ROS, glutathione depletion and calcein uptake W.G.E.J. Schoonen, Walter M.A. Westerink, Jeroen A.D.M. de Roos, Toxicology in Vitro Mechanistic AssaysBiochemistryMedicineLipid PeroxidationToxicology	2005	119
Evaluation of the Vitotox™ and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development Walter M.A. Westerink, Joe C.R. Stevenson, Annick Lauwers, Mutation Research/Genetic Toxicology and Environmental Mutagenesis Preclinical Drug EvaluationRadarscreen AssaysDrug DiscoveryPharmacologyToxicology Testing	2009	74
The development of RAD51C, Cystatin A, p53 and Nrf2 luciferase-reporter assays in metabolically competent HepG2 cells for the assessment of mechanism-based genotoxicity and of oxidative stress in the early research phase of drug development Walter M.A. Westerink, Joe C.R. Stevenson, G. Jean Horbach, Mutation Research/Genetic Toxicology and Environmental Mutagenesis Reductive StressMedicineLipid PeroxidationHepatotoxicityCystatin A	2009	73
Development and validation of a high-content screening in vitro micronucleus assay in CHO-k1 and HepG2 cells Walter M.A. Westerink, Tom J.J. Schirris, G. Jean Horbach, Mutation Research/Genetic Toxicology and Environmental Mutagenesis MedicineHepg2 CellsBioanalysisHistopathologyHepatitis	2011	67
Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition Walter M.A. Westerink, Joe C.R. Stevenson, W.G.E.J. Schoonen Archives of Toxicology Molecular PharmacologyBiochemistryPharmacologic ProfilingMedicineCytochrome P450 1A1	2008	41
Robust Array-Based Coregulator Binding Assay Predicting ERα-Agonist Potency and Generating Binding Profiles Reflecting Ligand Structure J.M.M.J.G. Aarts, Si Wang, René Houtman, Chemical Research in Toxicology Drug TargetComparative EndocrinologyEstrogen ReceptorBinding ProfilesPeptide Science	2013	32
Cytotoxic effects of 109 reference compounds on rat H4IIE and human HepG2 hepatocytes. III: Mechanistic assays on oxygen consumption with MitoXpress and NAD(P)H production with Alamar Blue™ W.G.E.J. Schoonen, Joe C.R. Stevenson, Walter M.A. Westerink, Toxicology in Vitro Redox SignalingBiochemistryMedicineLiver PhysiologyPhysiology	2012	26

Page 1